Steven Valiquette
Stock Analyst at Mizuho
(3.42)
# 981
Out of 5,005 analysts
112
Total ratings
56.9%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Neutral | $750 → $770 | $738.06 | +4.33% | 4 | Sep 24, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $295 → $325 | $296.28 | +9.69% | 4 | Aug 29, 2025 | |
| PHR Phreesia | Initiates: Outperform | $36 | $23.27 | +54.71% | 1 | Aug 27, 2025 | |
| NVST Envista Holdings | Maintains: Underperform | $15 → $18 | $20.85 | -13.67% | 2 | Aug 1, 2025 | |
| TDOC Teladoc Health | Initiates: Neutral | $10 | $9.01 | +10.99% | 1 | Jul 25, 2025 | |
| WAY Waystar Holding | Initiates: Outperform | $48 | $38.64 | +24.22% | 1 | Jun 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $73.26 | -18.10% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $132.17 | +85.37% | 11 | Apr 29, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $154.46 | -2.89% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $13.19 | +36.47% | 7 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $70 → $82 | $74.00 | +10.81% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $6.97 | +0.43% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $126 | $88.59 | +42.23% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $67.03 | +11.89% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.76 | +81.16% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $4.76 | +194.12% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $207.24 | -31.48% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $69.76 | -21.16% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $175.04 | -47.44% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $360.20 | +56.86% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $77.49 | +29.05% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $5.54 | +152.71% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $201.97 | +98.05% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $38.70 | +176.49% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $35.49 | -52.10% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $8.06 | +48.88% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $123.23 | -22.10% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $179.33 | -33.08% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $429.54 | -70.43% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $283.72 | +26.18% | 3 | Dec 6, 2019 |
McKesson
Sep 24, 2025
Maintains: Neutral
Price Target: $750 → $770
Current: $738.06
Upside: +4.33%
Veeva Systems
Aug 29, 2025
Maintains: Outperform
Price Target: $295 → $325
Current: $296.28
Upside: +9.69%
Phreesia
Aug 27, 2025
Initiates: Outperform
Price Target: $36
Current: $23.27
Upside: +54.71%
Envista Holdings
Aug 1, 2025
Maintains: Underperform
Price Target: $15 → $18
Current: $20.85
Upside: -13.67%
Teladoc Health
Jul 25, 2025
Initiates: Neutral
Price Target: $10
Current: $9.01
Upside: +10.99%
Waystar Holding
Jun 30, 2025
Initiates: Outperform
Price Target: $48
Current: $38.64
Upside: +24.22%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $73.26
Upside: -18.10%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $132.17
Upside: +85.37%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $154.46
Upside: -2.89%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $13.19
Upside: +36.47%
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $74.00
Upside: +10.81%
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $6.97
Upside: +0.43%
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $88.59
Upside: +42.23%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $67.03
Upside: +11.89%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.76
Upside: +81.16%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $4.76
Upside: +194.12%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $207.24
Upside: -31.48%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $69.76
Upside: -21.16%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $175.04
Upside: -47.44%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $360.20
Upside: +56.86%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $77.49
Upside: +29.05%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $5.54
Upside: +152.71%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $201.97
Upside: +98.05%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $38.70
Upside: +176.49%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $35.49
Upside: -52.10%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $8.06
Upside: +48.88%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $123.23
Upside: -22.10%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $179.33
Upside: -33.08%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $429.54
Upside: -70.43%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $283.72
Upside: +26.18%